AGTR1 and chronic kidney disease: In a non-CKD model of elastocalcinosis induced by warfarin and vitamin K1 treatment in rats, long-term treatment with the AT1 receptor antagonist irbesartan was effective in preventing vascular calcification, but was of limited effectiveness in preventing the progression of vascular calcification despite a reduction in vascular remodeling (26).